The PI3K AKT Pathway as a Target for Cancer Treatment von Mayer, Ingrid A, Arteaga, Carlos L

Volltext

Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast Cancer von Nunnery, Sara E., Mayer, Ingrid A.

Volltext

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment von Guerrero-Zotano, Angel, Mayer, Ingrid A., Arteaga, Carlos L.

Volltext

Alpelisib for PIK3CA-Mutated, Hormone Receptor–Positive Advanced Breast Cancer von André, Fabrice, Ciruelos, Eva, Rubovszky, Gabor, Campone, Mario, Loibl, Sibylle, Rugo, Hope S, Iwata, Hiroji, Conte, Pierfranco, Mayer, Ingrid A, Kaufman, Bella, Yamashita, Toshinari, Lu, Yen-Shen, Inoue, Kenichi, Takahashi, Masato, Pápai, Zsuzsanna, Longin, Anne-Sophie, Mills, David, Wilke, Celine, Hirawat, Samit, Juric, Dejan

Volltext

New Strategies for Triple-Negative Breast Cancer—Deciphering the Heterogeneity von MAYER, Ingrid A, ABRAMSON, Vandana G, LEHMANN, Brian D, PIETENPOL, Jennifer A

Volltext

Resistance to Trastuzumab in Breast Cancer von POHLMANN, Paula R, MAYER, Ingrid A, MERNAUGH, Ray

Volltext

Prevention of everolimus-related stomatitis in women with hormone receptor-positive, HER2-negative metastatic breast cancer using dexamethasone mouthwash (SWISH): a single-arm, pha... von Rugo, Hope S, Dr Prof, Seneviratne, Lasika, MD, Beck, J Thaddeus, MD, Glaspy, John A, Prof, Peguero, Julio A, MD, Pluard, Timothy J, MD, Dhillon, Navneet, MD, Hwang, Leon Christopher, MD, Nangia, Chaitali, MD, Mayer, Ingrid A, MD, Meiller, Timothy F, Prof, Chambers, Mark S, Prof, Sweetman, Robert W, MD, Sabo, J Randy, MPH, Litton, Jennifer K, MD

Volltext

Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 tri... von Krop, Ian E, Dr, Mayer, Ingrid A, MD, Ganju, Vinod, FRACP, Dickler, Maura, MD, Johnston, Stephen, MD, Morales, Serafin, MD, Yardley, Denise A, MD, Melichar, Bohuslav, Prof, Forero-Torres, Andres, MD, Lee, Soo Chin, MRCP, de Boer, Richard, FRACP, Petrakova, Katarina, PhD, Vallentin, Susanne, MD, Perez, Edith A, MD, Piccart, Martine, Prof, Ellis, Matthew, Prof, Winer, Eric, Prof, Gendreau, Steven, PhD, Derynck, Mika, MD, Lackner, Mark, PhD, Levy, Gallia, MD, Qiu, Jiaheng, PhD, He, Jing, MD, Schmid, Peter, Prof

Volltext

Multiparametric Magnetic Resonance Imaging for Predicting Pathological Response After the First Cycle of Neoadjuvant Chemotherapy in Breast Cancer von Li, Xia, Abramson, Richard G, Arlinghaus, Lori R, Kang, Hakmook, Chakravarthy, Anuradha Bapsi, Abramson, Vandana G, Farley, Jaime, Mayer, Ingrid A, Kelley, Mark C, Meszoely, Ingrid M, Means-Powell, Julie, Grau, Ana M, Sanders, Melinda, Yankeelov, Thomas E

Volltext

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexp... von RIMAWI, Mothaffar F, MAYER, Ingrid A, SCHIFF, Rachel, KENT OSBORNE, C, CHANG, Jenny C, FORERO, Andres, NANDA, Rita, GOETZ, Matthew P, RODRIGUEZ, Angel A, PAVLICK, Anne C, TAO WANG, HILSENBECK, Susan G, GUTIERREZ, Carolina

Volltext

Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer von Yan, Chi, Yang, Jinming, Saleh, Nabil, Chen, Sheau-Chiann, Ayers, Gregory D., Abramson, Vandana G., Mayer, Ingrid A., Richmond, Ann

Volltext

A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer von Schöffski, Patrick, Cresta, Sara, Mayer, Ingrid A, Wildiers, Hans, Damian, Silvia, Gendreau, Steven, Rooney, Isabelle, Morrissey, Kari M, Spoerke, Jill M, Ng, Vivian W, Singel, Stina M, Winer, Eric

Volltext

DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: Pilot study findings von Li, Xia, Arlinghaus, Lori R., Ayers, Gregory D., Chakravarthy, A. Bapsi, Abramson, Richard G., Abramson, Vandana G., Atuegwu, Nkiruka, Farley, Jaime, Mayer, Ingrid A., Kelley, Mark C., Meszoely, Ingrid M., Means-Powell, Julie, Grau, Ana M., Sanders, Melinda, Bhave, Sandeep R., Yankeelov, Thomas E.

Volltext

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents von Goodwin, Pamela J, Stambolic, Vuk, Lemieux, Julie, Chen, Bingshu E, Parulekar, Wendy R, Gelmon, Karen A, Hershman, Dawn L, Hobday, Timothy J, Ligibel, Jennifer A, Mayer, Ingrid A, Pritchard, Kathleen I, Whelan, Timothy J, Rastogi, Priya, Shepherd, Lois E

Volltext

Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets von Korolkova, Olga Y., Widatalla, Sarrah E., Whalen, Diva S., Nangami, Gladys N., Abimbola, Adeniyi, Williams, Stephen D., Beasley, Heather K., Reisenbichler, Emily, Washington, Mary Kay, Ochieng, Josiah, Mayer, Ingrid A., Lehmann, Brian D., Sakwe, Amos M.

Volltext

Enabling a Genetically Informed Approach to Cancer Medicine: A Retrospective Evaluation of the Impact of Comprehensive Tumor Profiling Using a Targeted Next‐Generation Sequencing P... von Johnson, Douglas B., Dahlman, Kimberly H., Knol, Jared, Gilbert, Jill, Puzanov, Igor, Means‐Powell, Julie, Balko, Justin M., Lovly, Christine M., Murphy, Barbara A., Goff, Laura W., Abramson, Vandana G., Crispens, Marta A., Mayer, Ingrid A., Berlin, Jordan D., Horn, Leora, Keedy, Vicki L., Reddy, Nishitha M., Arteaga, Carlos L., Sosman, Jeffrey A., Pao, William

Volltext

Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results von Yankeelov, Thomas E, Lepage, Martin, Chakravarthy, Anuradha, Broome, Elizabeth E, Niermann, Kenneth J, Kelley, Mark C, Meszoely, Ingrid, Mayer, Ingrid A, Herman, Cheryl R, McManus, Kevin, Price, Ronald R, Gore, John C

Volltext

Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases von Challa, Anup P., Zaleski, Nicole M., Jerome, Rebecca N., Lavieri, Robert R., Shirey-Rice, Jana K., Barnado, April, Lindsell, Christopher J., Aronoff, David M., Crofford, Leslie J., Harris, Raymond C., Ikizler, T. Alp, Mayer, Ingrid A., Holroyd, Kenneth J., Pulley, Jill M.

Volltext

Statistical comparison of dynamic contrast-enhanced MRI pharmacokinetic models in human breast cancer von Li, Xia, Welch, E. Brian, Chakravarthy, A. Bapsi, Xu, Lei, Arlinghaus, Lori R., Farley, Jaime, Mayer, Ingrid A., Kelley, Mark C., Meszoely, Ingrid M., Means-Powell, Julie, Abramson, Vandana G., Grau, Ana M., Gore, John C., Yankeelov, Thomas E.

Volltext

Short Preoperative Treatment With Erlotinib Inhibits Tumor Cell Proliferation in Hormone Receptor–Positive Breast Cancers von GUIX, Marta, DE MATOS GRANJA, Nara, PESTANO, Gary, SHYR, Yu, MUTHUSWAMY, Senthil, CALVO, Benjamin, KRONTIRAS, Helen, KROP, Ian E, KELLEY, Mark C, ARTEAGA, Carlos L, MESZOELY, Ingrid, ADKINS, Theresa B, WIEMAN, Bobbye M, FRIERSON, Kerek E, SANCHEZ, Violeta, SANDERS, Melinda E, GRAU, Ana M, MAYER, Ingrid A

Volltext